
Pharmacally
CML
Approvals, trial readouts, research and drug safety alerts, interpreted by pharmacists and checked against the primary source.
Latest in CML
Clinical TrialsFDA Backs Phase 3 Plan as Enliven Posts Strong Phase 1 CML ResultsUpdated Phase 1 ENABLE data presented at EHA 2026 showed strong molecular responses and favorable tolerability with ELVN-001 in pretreated CML.Fact-Checked
Health TidingsTerns Advances TERN-701 with FDA Breakthrough Therapy Designation in CMLThe U.S. Food and Drug Administration grants Breakthrough Therapy Designation to TERN-701, an oral BCR::ABL1 inhibitor from Terns Pharmaceuticals, Inc., following encouraging clinical responses and safety data in…Fact-Checked
Explore more
Health TidingsIndustry, pipeline and company news.
RegulatoryApprovals, policy and agency decisions.
ResearchPeer-reviewed studies and scientific breakthroughs.
Drug FinderLook up any drug: uses, dosing and safety.
From the HistoryLandmark moments in pharmaceutical history.
LatestEvery new story, as soon as it is published.